论文部分内容阅读
Calfarit是以胶囊包装的阿司匹林的商品药名,作者用此药治疗视网膜静脉血栓形成41例,其中有静脉血栓形成前期6例,静脉主干血栓形成14例及静脉分枝血栓形成21例。在41例中绝大多数病人有糖尿病、动脉硬化及高血压病。静脉血栓形成前期是指血管闭塞不久,血小板凝块还是可逆的,眼底视网膜动静脉交叉现象显著,静脉扩张,没有出血。这组病例在治疗后,全部病例于4～6周内痊愈,血管重新畅通。用药方法是先口服Calfarit每天3次,每次一颗,连续两周,以后改为每天1～2颗,予防复发。
Calfarit is a commercial name for aspirin in capsules. The authors used this drug to treat 41 cases of retinal vein thrombosis, including 6 cases of pre-venous thrombosis, 14 cases of venous trunk thrombosis and 21 cases of venous thrombosis. The vast majority of the 41 patients had diabetes, arteriosclerosis and hypertension. Venous thrombosis is the pre-vascular occlusion soon, platelet clot or reversible retinal vein retinal cross phenomenon was significant, venous dilatation, no bleeding. This group of patients after treatment, all cases recovered within 4 to 6 weeks, vascular reopened. Medication is the first oral Calfarit 3 times a day, one each for two consecutive weeks later changed to 1 or 2 days to prevent recurrence.